Search by Color or Cause
Fabry Disease Awareness Month is observed in April. During this time, advocates educate and raise awareness about Fabry disease, and the way to recognize, diagnose and understand its management. Both Fabry disease Awareness Month and the blue ribbon call attention to Fabry disease. Fabry disease is a rare disease that interferes with the body’s ability to break down specific fatty substances. It is more common in women. However, it occurs with greater severity in men.
Fabry disease is a rare genetic condition in which a person doesn’t produce enough healthy versions of an enzyme called alpha-galactosidase A (alpha-GAL). This enzyme breaks down sphingolipids, a fat-like substance. Without functioning alpha-GAL enzymes, harmful levels of sphingolipids build up in blood vessels and tissues. In addition, Fabry disease affects the heart, kidneys, brain, central nervous system and skin. Fabry disease is a type of lysosomal storage disorder.
Lastly, other names for the condition are Anderson-Fabry disease, Fabry’s disease and alpha-galactosidase-A deficiency.
The types of Fabry disease reflect the age when symptoms first appear. Types include:
Approximately 1 out of every 40,000 men and people assigned male at birth (AMAB) has classic Fabry disease. However, late-onset or atypical Fabry disease is more common. It affects about 1 in every 1,500 to 4,000 men and people AMAB.
Experts aren’t sure how many women and people assigned female at birth (AFAB) have Fabry disease. Some women and people AFAB don’t have symptoms or have mild, easy-to-dismiss symptoms, so the condition frequently goes undiagnosed.
People with Fabry disease inherit a mutated gene on their X chromosome from a biological parent. Men and people AMAB inherit one X chromosome from their female parent. Women and people AFAB have two X chromosomes, one from each parent.
A parent can pass on the faulty gene that causes Fabry disease to a child in different ways. For example,
Fabry disease symptoms vary depending on the type. Some symptoms are mild and might not appear until later in life. Men and people AMAB tend to have more severe Fabry disease symptoms than women and people AFAB. Fabry disease symptoms include:
A genetic mutation of the galactosidase alpha (GLA) gene causes Fabry disease. The GLA gene produces the alpha-GAL enzyme that helps break down fatty substances (sphingolipids). People who inherit a defective GLA gene don’t produce enough alpha-GAL enzyme. As a result, fatty substances build up in their blood vessels.
Years of buildup of the fatty substance can damage blood vessels and lead to life-threatening issues, including:
Join us in spreading awareness about this rare, under-diagnosed, yet treatable disease. A better understanding can ultimately lead to better and longer lives for people with Fabry disease. During the month of April, we raise awareness for Fabry disease by educating patients and family members, caregivers, healthcare professionals and the greater community to improve the recognition, diagnosis, understanding, and management of Fabry disease.